// src/app/blog/thailand-hemp-cbd-market-2026/page.tsx
import type { Metadata } from "next";
import ArticleLayout from "@/components/blog/ArticleLayout";
import { getPostBySlug } from "@/lib/blog-posts";

const post = getPostBySlug("thailand-hemp-cbd-market-2026")!;

export const metadata: Metadata = {
  title: `${post.title}`,
  description: post.description,
  alternates: { canonical: `/blog/${post.slug}` },
  openGraph: { title: post.title, description: post.description, url: `https://www.globalgreenexport.com/blog/${post.slug}`, type: "article" },
};

export default function Page() {
  return (
    <ArticleLayout post={post}>
      <p>
        Thailand's position in the global hemp trade isn't an accident of
        timing — it's the result of being first. Thailand was the first
        country in Asia to legalize the cultivation, extraction, and
        commercial use of hemp-derived CBD, and that first-mover position
        has had time to compound into a genuinely developed supply chain,
        not just a legal permission slip.
      </p>

      <h2 className="font-display text-[28px] text-[var(--ink)] mt-12 mb-2">What "first" actually bought Thailand</h2>
      <p>
        Legalizing hemp is one thing. Building the infrastructure to
        actually process, test, and export it at commercial volume is
        another, and that's where the time advantage matters. Extraction
        facilities, independent testing labs, and export documentation
        processes that would take a newly-legalizing market years to
        establish are already operating at scale in Thailand. For a
        wholesale buyer, that shows up as shorter lead times, more
        consistent batch quality, and suppliers who've already worked
        through the documentation questions a newer market's suppliers are
        still figuring out.
      </p>

      <h2 className="font-display text-[28px] text-[var(--ink)] mt-12 mb-2">Two supply chains, not one</h2>
      <p>
        It's worth being precise about what Thailand's legalization
        actually covers, because it's easy to conflate hemp and cannabis
        market maturity when they're genuinely separate regulatory tracks.
        Hemp — low-THC, broadly under the 0.2% national threshold used for
        classification — sits in an open commercial framework that's scaled
        quickly. High-THC cannabis remains a controlled Category 5 narcotic
        with a much smaller, more tightly licensed export pathway. A
        supplier's strength in hemp sourcing doesn't automatically translate
        to cannabis export capability, and vice versa — worth confirming
        which track applies to your specific order.
      </p>

      <h2 className="font-display text-[28px] text-[var(--ink)] mt-12 mb-2">What this means for wholesale buyers right now</h2>
      <p>
        The practical upshot for a buyer sourcing CBD, CBG, or CBN isolates
        at wholesale volume: Thailand's hemp supply chain has enough
        maturity that batch-to-batch consistency and documentation quality
        are less of a gamble than they'd be sourcing from a market still
        building out its testing and export infrastructure. That doesn't
        remove the need for due diligence — CoA verification, THC threshold
        confirmation for your specific destination market, and origin
        documentation still matter on every order — but the baseline
        reliability of Thai hemp sourcing has genuinely improved as the
        industry has matured since legalization.
      </p>
      <p>
        The overall trajectory of Thailand's regulated herbal export sector
        — cumulative export value has continued climbing, with volume
        measured in the hundreds of thousands of kilograms across
        controlled herbal categories — reflects a market that's moved past
        the early, exploratory phase into something closer to established
        trade infrastructure. For buyers weighing where to source hemp
        derivatives at scale, that maturity is the actual differentiator,
        more than any single regulatory headline.
      </p>
    </ArticleLayout>
  );
}
